Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma

Programmed cell death ligand 1 (PD-L1) and its receptor PD-1 are immune checkpoint molecules that attenuate the immune response. Blockade of PD-L1 enhances the immune response in a variety of tumours and thus serves as an effective anti-cancer treatment. However, the biological and prognostic roles...

Full description

Bibliographic Details
Main Authors: Goto, Y. (Author), Hashiguchi, Y. (Author), Jinno, T. (Author), Kaneko, N. (Author), Kawano, S. (Author), Kitamura, R. (Author), Kiyoshima, T. (Author), Maruse, Y. (Author), Matsubara, R. (Author), Moriyama, M. (Author), Nakamura, S. (Author), Oobu, K. (Author), Sakamoto, T. (Author), Tanaka, H. (Author), Toyoshima, T. (Author)
Format: Article
Language:English
Published: Churchill Livingstone 2018
Subjects:
Online Access:View Fulltext in Publisher